A soluble CAR‐SCF fusion protein improves adenoviral vector‐mediated gene transferto c‐Kit‐positive hematopoietic cells
Authors:
- 16 June 2003
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 5 (11) , 929-940
Abstract
Background: Although adenoviral vectors primarily derived from the adenovirus serotype 5 (Ad5) are widely used for many gene transfer applications, they cannot efficiently infect hematopoietic cells, since these cells do not express the coxsackie‐adenoviral receptor (CAR).Methods: We have developed a soluble fusion protein that bridges adenoviral fibers and the c‐Kit receptor to alter Ad5 tropism to immature hematopoietic cells. The CAR‐SCF fusion protein consists of the extracellular domains of CAR and stem cell factor (SCF). The human megakaryoblastic leukemia cell lines UT‐7 and M07e, human chronic myelogenous leukemia cell line K‐562, and erythroleukemia cell line TF‐1 were used to assess CAR‐SCF‐assisted Ad5‐mediated gene transfer. Hematopoietic cell lines were infected with an Ad5 vector (Ad5‐eGFP) or a fiber‐mutant Ad5/F35 (Ad5/F35‐eGFP) expressing the enhanced green fluorescent protein gene in the presence or absence of CAR‐SCF.Results: Twenty‐four hours after infection, more than 80% of M07e cells infected in the presence of CAR‐SCF were eGFP‐positive, compared with very few eGFP‐positive cells following Ad5‐eGFP infection in the absence of CAR‐SCF. The enhancement of Ad5‐eGFP infection by CAR‐SCF was greater than that caused by Ad5/F35‐eGFP (50%). The ability of CAR‐SCF to enhance Ad5‐eGFP infectivity was highly dependent on cellular c‐Kit expression levels. Furthermore, CAR‐SCF also enhanced Ad5‐mediated gene transfer into human primary CD34+ cells.Conclusions: The CAR‐SCF fusion protein assists Ad5‐mediated transduction to c‐Kit+ CAR− hematopoietic cells. The use of this fusion protein would enhance a utility of Ad5‐mediated hematopoietic cell transduction strategies. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 38 references indexed in Scilit:
- Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of DiseaseJournal of Virology, 2002
- Efficient and Selective Gene Transfer into Primary Human Brain Tumors by Using Single-Chain Antibody-Targeted Adenoviral Vectors with Native Tropism AbolishedJournal of Virology, 2002
- Targeting Adenoviral Vectors by Using the Extracellular Domain of the Coxsackie-Adenovirus Receptor: Improved Potency via TrimerizationJournal of Virology, 2002
- Efficient c-kit Receptor-Targeted Gene Transfer to Primary Human CD34-Selected Hematopoietic Stem CellsJournal of Virology, 2001
- Highly Efficient Targeted Transduction of Undifferentiated Human Hematopoietic Cells by Adenoviral Vectors Displaying Fiber Knobs of Subgroup BHuman Gene Therapy, 2001
- A Capsid-Modified Adenovirus Vector Devoid of All Viral Genes: Assessment of Transduction and Toxicity in Human Hematopoietic CellsMolecular Therapy, 2001
- Selective Transduction of Murine Myelomonocytic Leukemia Cells (WEHI-3B) with Regular and RGD-Adenoviral VectorsMolecular Therapy, 2001
- Maturation and Lineage‐Specific Expression of the Coxsackie and Adenovirus Receptor in Hematopoietic CellsStem Cells, 2000
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993
- Expression and modulation of IL‐3 and GM‐CSF receptors in human growth factor dependent leukaemic cellsBritish Journal of Haematology, 1990